Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome

By Lanzone A.   Fulghesu A.M.   Guido M.   Cucinelli F.   Caruso A.   Mancuso S.  

Fertility and Sterility, Vol. 67, Iss. 1, 1997-01 ,pp. : 34-39

Elsevier

Access to resources Recommend Favorite

Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome

By Comim F.V.   Spritzer P.M.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 108-113

Elsevier

Access to resources Recommend Favorite

Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome

By Wu X.-K.   Sallinen K.   Zhou S.-Y.   Su Y.-H.   Pollanen P.   Erkkola R.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 730-734

Elsevier

Access to resources Recommend Favorite

Molecular analysis of the gonadotropin-releasing hormone receptor in patients with polycystic ovary syndrome

By Cohen D.P.   Stein E.M.   Li Z.   Matulis C.K.   Ehrmann D.A.   Layman L.C.  

Fertility and Sterility, Vol. 72, Iss. 2, 1999-08 ,pp. : 360-363

Elsevier

Access to resources Recommend Favorite

Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone

By Kondoh Y.   Uemura T.   Ishikawa M.   Yokoi N.   Hirahara F.  

Fertility and Sterility, Vol. 72, Iss. 1, 1999-07 ,pp. : 15-20

Elsevier

Access to resources Recommend Favorite